Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)
| 3.09 Data as of Jul 22 |  -0.07 / -2.22%Today’s Change | 2.75 Today|||52-Week Range 5.50 | -23.13% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Assets | Cash | -- | 4.6M | 4.1M | 4.7M | |
| Short Term Investment Cash | -- | -5.0M | -8.0M | 14.7M | ||
| Cash & Short Term Investments | 29.5M | 24.4M | 16.4M | 31.1M | ||
| Receivables | Receivables | -- | 541.0K | 1.0M | 2.3M | |
| Inventories | Inventories | -- | 182.0K | 0.00 | 0.00 | |
| Current Assets | Prepaid Expenses | -- | 321.0K | 358.0K | 427.0K | |
| Other Current Assets | -- | 338.0K | 1.1M | 1.3M | ||
| Current Assets | -- | 25.8M | 18.9M | 35.2M | ||
| Total Assets | Property, Plant and Equipment - Gross | -- | 8.4M | 7.7M | 7.9M | |
| Depreciation | -- | -8.2M | -7.6M | -7.7M | ||
| Other Assets | -- | 0.00 | 353.0K | 72.0K | ||
| Total Assets | 31.5M | 26.0M | 19.4M | 35.5M | ||
| Liabilities | Accounts Payable | -- | 1.8M | 2.3M | 2.5M | |
| Accrued Expenses | -- | 3.5M | 4.7M | 3.8M | ||
| Other Current Liabilities | -- | 4.7M | 7.1M | 5.0M | ||
| Other Liabilities | -- | 6.5M | 9.3M | 7.5M | ||
| Total Liabilities | Other Liabilities | 6.5M | 0.00 | 0.00 | 0.00 | |
| Total Liabilities | 6.5M | 6.5M | 9.3M | 7.5M | ||
| Equity | Minority Interest | -- | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 13.3M | 13.7M | 1.0K | 0.00 | ||
| Common Equity | 11.6M | 5.8M | 10.0M | 28.0M | ||
| Total Shareholder Equity | 24.9M | 19.5M | 10.0M | 28.0M | ||
| Share Information | Common Shares Outstanding | 6.7M | 7.7M | 8.7M | 19.4M | |
| Addtl. Info. | No data currently available for this section. | |||||
.
